(Q41507555)

1 October 2017

GLC Assay of Verapamil in Plasma: Identification of Fluorescent Metabolites after Oral Drug Administration (English)

1 reference

https://api.crossref.org/works/10.1002/JPS.2600680515

6 May 2023

1 reference

pharmaceutical science

1 reference

https://api.crossref.org/works/10.1002/JPS.2600680515

6 May 2023

author name string

McAllister RG Jr

1

1 reference

1 October 2017

R. G. McAllister

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A430493

6 May 2023

T. G. Tan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A430493

6 May 2023

D. W. Bourne

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A430493

6 May 2023

language of work or name

English

0 references

publication date

1 May 1979

1 reference

full work available at URL

1 October 2017

https://api.elsevier.com/content/article/PII:S0022354915426280?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1002/JPS.2600680515

https://api.elsevier.com/content/article/PII:S0022354915426280?httpAccept=text/plain

6 May 2023

1 reference

https://api.crossref.org/works/10.1002/JPS.2600680515

Journal of Pharmaceutical Sciences

6 May 2023

published in

1 reference

1 October 2017

68

1 reference

1 October 2017

5

1 reference

1 October 2017

574-577

1 reference

A fourth class of anti-dysrhythmic action? Effect of verapamil on ouabain toxicity, on atrial and ventricular intracellular potentials, and on other features of cardiac function

1 October 2017

1

1 reference

https://api.crossref.org/works/10.1002/JPS.2600680515

Verapamil in the management of supraventricular tachyarrhythmias occurring after a recent myocardial infarction

6 May 2023

2

1 reference

https://api.crossref.org/works/10.1002/JPS.2600680515

Immediate Effects of Intravenous Verapamil in Cardiac Arrhythmias

6 May 2023

3

1 reference

https://api.crossref.org/works/10.1002/JPS.2600680515

A protective effect of verapamil on hypoxic heart muscle

6 May 2023

4

1 reference

https://api.crossref.org/works/10.1002/JPS.2600680515

Journal of Pharmacology and Experimental Therapeutics

6 May 2023

6

189

414

Rosen

1974

1 reference

https://api.crossref.org/works/10.1002/JPS.2600680515

Editorial: Calcium responses ("calcium spikes").

6 May 2023

8

1 reference

https://api.crossref.org/works/10.1002/JPS.2600680515

Fluorometric Assay of Verapamil in Biological Fluids and Tissues

6 May 2023

9

1 reference

https://api.crossref.org/works/10.1002/JPS.2600680515

Electrophysiologic and hemodynamic effects of verapamin. Correlation with plasma drug concentrations

6 May 2023

11

1 reference

https://api.crossref.org/works/10.1002/JPS.2600680515

Metabolism of [14C]-verapamil

6 May 2023

13

1 reference

https://api.crossref.org/works/10.1002/JPS.2600680515

Physiological disposition of verapamil in man

6 May 2023

14

1 reference

https://api.crossref.org/works/10.1002/JPS.2600680515

6 May 2023

Identifiers

1 reference

1 October 2017

1 reference